In mouse models bearing lung cancer, melittin inhibited tumor growth and increased TAMs M1/M2 ratio by selectively decreasing CD206+ M2-like TAMs, VEGF, CD31 (angiogenesis marker), and Mrc1/CD206 protein and gene expression in tumor cells. This evidence concerns the gene MRC1 and lung carcinoma.